Priority Date: 18.07.12 (US 201261741425P)

NOVEL ARTERIVIRUS PROTEIN AND EXPRESSION MECHANISMS

  • Application ID: EP13742799
  • Status: EXAMINATION IN PROGRESS

Applicants

Company dna cambridge enterprise ltd
Technology Transfer Office

Attorney

operating since 1891
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 127 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 18.07.2012 - Priority Date (US 201261741425P)
  • 23.01.2014 - Publication A2 (WO2014015116)
  • 27.05.2015 - Publication A2 (EP2874654)

IPC Classification